Table Graph
      published meta-analysis   sensitivity analysis   studies

non-steroidal anti-inflammatory drugs in COVID-19 (hospitalized or not) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsPark, 2021 1.35 [0.63; 2.89] 1.35[0.63; 2.89]Park, 202110%794NAnot evaluable deathsdetailed resultsPark, 2021 1.33 [0.62; 2.84] 1.33[0.62; 2.84]Park, 202110%794NAnot evaluable deaths (time to event analysis only)detailed resultsPark, 2021 1.33 [0.62; 2.84] 1.33[0.62; 2.84]Park, 202110%794NAnot evaluable mechanical ventilationdetailed resultsPark, 2021 1.61 [0.52; 4.97] 1.61[0.52; 4.97]Park, 202110%790NAnot evaluable mechanical ventilation (time to event analysis only)detailed resultsPark, 2021 1.60 [0.51; 5.06] 1.60[0.51; 5.06]Park, 202110%794NAnot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-07-08 18:50 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 87 - treatments: 668,753,752,836 - roots T: 290

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons